SULFONAMIDVERBINDUNG

European patent · EP2896613 · Deleted

Register entry

Publication number
EP2896613
Application number
EP13837919
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 13, 2013
Published
Jul 22, 2015
Granted
Mar 21, 2018
Deleted
Sep 30, 2018
Reason
Annual fee unpaid
IPC classes
C07D 217/22 (2006.01)
A61K 31/472 (2006.01)
A61K 31/4725 (2006.01)
A61K 31/5377 (2006.01)
A61P 1/00 (2006.01)
A61P 11/00 (2006.01)
A61P 13/00 (2006.01)
A61P 15/00 (2006.01)
A61P 17/00 (2006.01)
A61P 25/00 (2006.01)
A61P 25/04 (2006.01)
A61P 25/06 (2006.01)
A61P 35/00 (2006.01)
A61P 43/00 (2006.01)
C07D 401/12 (2006.01)
C07D 401/14 (2006.01)
C07D 413/12 (2006.01)
C07D 413/14 (2006.01)
Priority
JP 2012203126 14.09.2012
JP 2012203128 14.09.2012
PCT application
PCT/JP2013/074812 13.09.2013
PCT publication
WO2014/042238 20.03.2014
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 17, 2019

    Deleted, fee unpaid

    Published in Swissreg on 17.04.2019

  2. Mar 21, 2018

    Granted

    Published in Swissreg on 21.03.2018

Parties

Holder

Mitsubishi Tanabe Pharma Corporation

3-2-10, Dosho-machi, Chuo-ku, Osaka-shi, Osaka 541-8505, JP

Inventor

KATO, Taku

Osaka-shi Osaka 541-8505, JP

SAKAMOTO, Toshiaki

Osaka-shi Osaka 541-8505, JP

KUBO, Akira

Osaka-shi Osaka 541-8505, JP

SAWAMOTO, Daisuke

Osaka-shi Osaka 541-8505, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.